Recursion Pharmaceuticals, Inc. (RXRX)

3.445 +0.06 (+1.62%) USD  |  NASDAQ  |  May 04, 11:45
More

Recursion Pharmaceuticals Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for RXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Quince Therapeutics, Inc. Upgrade